Ionis Pharmaceuticals’ Dr. C. Frank Bennett Receives Prestigious Breakthrough Prize in Life Sciences in Recognition of the Transformational Drug SPINRAZA® and Ionis’ Antisense Technology
……………
C. Frank Bennett, the head of research at Ionis Pharmaceuticals, and Adrian R. Krainer, the St. Giles Foundation professor at Cold Spring Harbor Laboratory, will share a $3 million Breakthrough Prize for their role in developing Spinraza, a drug against spinal muscular atrophy that was invented by Ionis and is marketed by Biogen.
The Breakthrough Prizes, an “Oscars of Science” sponsored by Sergey Brin, Priscilla Chan and Mark Zuckerberg, Ma Huateng, Yuri and Julia Milner and Anne Wojcicki, pay out larger amounts than any other scientific award. This year, a total of $22 million will be awarded in a televised awards ceremony on November 4.
